InVivo Therapeutics Holdings Corp. announced promotions for two members of its management team. Christopher McNulty has been appointed as Senior Vice President, Business Development and Investor Relations. He will continue to lead all business development and corporate communications efforts, including investor
relations and public relations. This role is a promotion from his previous role as Vice President, Business Development and Investor Relations. Before coming to InVivo in November 2013, Mr. McNulty served as Senior Director of Business Development at Repligen Corporation. Previously, he was Director of Corporate Development at Seventh Sense Biosystems, and Associate Director of Business Development and Alliance Management at Genzyme Corporation. Alex Aimetti, Ph.D., has been promoted to the newly created position of Senior Director, Medical Education and Scientific Support. In this new role, Dr. Aimetti will be responsible for leading and managing all professional medical education programs for InVivo. Dr. Aimetti joined InVivo in April 2012, and has served in positions of increasing responsibility including R&D Manager, Biomaterials, and most recently Associate R&D Director, Biomaterials. Before joining InVivo, Dr. Aimetti was a Postdoctoral Research Fellow in the laboratory of Robert Langer, Sc.D. at MIT. Dr. Aimetti received his Bachelor of Science degree from Worcester Polytechnic Institute and holds a doctorate in Chemical & Biological Engineering from the University of Colorado Boulder.